Market revenue in 2023 | USD 283.7 million |
Market revenue in 2030 | USD 469.0 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Sweden formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden is the fourth most attractive market in Western Europe for commercializing pharmaceutical drugs and medicines. Most of the local production is for exports, and most manufacturing firms are small- to medium-sized, with a few multinational corporations having local subsidiaries in the country.
High dependence on outsourcing activities in Sweden expands the opportunities for formulation development services. With an increasing number of companies looking beyond North America and EU5 countries to conduct clinical trials, Sweden presents itself as a viable and attractive location for these studies.
This shift in focus is expected to create opportunities for CROs, drug formulation development service providers, and other drug-related outsourcing service providers based in Sweden, boosting the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Sweden formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account